Khurram Jamil, Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT), sold 85,234 shares at $5.47 ($466K) on 2025-11-13, disclosed to the SEC on 2025-11-14.
Scheduled sale ($466k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.47 | 21,867 | $120K | 25.7% |
| 2 | $5.47 | 21,867 | $120K | 25.7% |
| 3 | $5.47 | 41,500 | $227K | 48.7% |
| Total | $5.47 avg | 85,234 | $466K | 100% |
| Filing → |
| GALT | SELL | 2026-06-25 | $24K | — | Filing → |
| GALT | SELL | 2026-05-28 | $2K | — | Filing → |
| GALT | SELL | 2026-01-06 | $465K | — | Filing → |